Blazer Prime HTD cardiac ablation catheter
FDA premarket approval P020025/S127 · decided 2020-06-04
Approval details
- PMA number
- P020025
- Supplement
- S127
- Supplement type
- Real-Time Process
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- Blazer Prime HTD cardiac ablation catheter
- Generic name
- catheter, percutaneous, cardiac ablation, for treatment of atrial flutter
- Applicant
- Boston Scientific
- Date received
- 2020-03-30
- Decision date
- 2020-06-04
- Days to decision
- 66 days
- Decision code
- APPR
- Product code
- OAD
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- St Paul, MN
- Statement
- Approval for a design change to the Control Wire Sleeve of the Blazer Prime HTD and Blazer Prime XP cardiac ablation catheters.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.